Ubiquitin-proteasome system regulating composition containing proteasome inhibitor, e.g. MG132, is useful for cardiovascular protection, e.g. in preventing or treating restenosis or cardiac hypertrophy

摘要

A pharmaceutical composition (A) for inhibiting and/or regulating the ubiquitin-proteasome system, especially for use in cardiological indications, contains an effective amount of a proteasome inhibitor (I).